Methylenedioxymethoxyethylamphetamine

Methylenedioxymethoxyethylamphetamine (MDMEO-MA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes. It is an analogue of MDMA (3,4-methylenedioxy-N-methylamphetamine) that is used as a recreational drug.

Chemistry

MDMEO-MA is a substituted amphetamine derivative that also has the methylenedioxy ring-substituted structure of methylenedioxyphenethylamine. The compound is a member of the methylenedioxyamphetamine (MDxx) family. Its full chemical name is 3,4-methylenedioxy-N-methoxyethylamphetamine.

Pharmacology

The pharmacological mechanisms of MDMEO-MA are not well understood. It is believed to work primarily by increasing the activity of the neurotransmitters serotonin, dopamine, and norepinephrine in the brain. This is achieved by inhibiting their reuptake, leading to an increased concentration of these neurotransmitters in the synaptic cleft.

Effects

The effects of MDMEO-MA are similar to those of other MDxx drugs, including MDMA. These effects include feelings of euphoria, increased sociability, and heightened sensory perception. However, the drug also has the potential to cause serious side effects, such as neurotoxicity, serotonin syndrome, and addiction.

Legal Status

In many countries, including the United States, MDMEO-MA is a controlled substance. It is classified as a Schedule I drug under the Controlled Substances Act in the United States, meaning it has a high potential for abuse and no accepted medical use.

See Also

• MDMA
• Methylenedioxyamphetamine
• Substituted amphetamine
• Psychoactive drug